Curis Provides Fourth Quarter 2022 Business Update
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
Source: prnewswire.com
📰 Partial Hematologic News
Partial Hematologic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Partial Hematologic. Real-time updates on events, politics, business and more.